Main > A1. CORP. INDEX. T-Tm > Targeted Genetics/P > 2009. 09.09.2009. (Genzyme)

---

Targeted Genetics Corporation (NASDAQ: TGEN) today announced the sale to Genzyme Corporation of certain assets, including manufacturing technologies and other adeno-associated viral (AAV) vector technology, for up to $7 million in cash. The purchased assets consist primarily of patents, know-how and manufacturing-related equipment. Genzyme also received a license to use certain technology and materials necessary for manufacturing AAV vectors.

http://ir.targen.com/phoenix.zhtml?c=84981&p=irol-newsArticle&ID=1329430&highlight=


2009. 09.09.2009. (Genzyme)'s products
This section has no products